Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. NGNE.NASDAQ

Neurogene Inc (NGNE NASDAQ) stock market data APIs

$43.55 -1.28(-2.9%) as of July 26, 2024
Price chart is built with Anychart

Neurogene Inc., a biotechnology company, develops genetic medicines for rare neurological diseases. The company's product candidates include NGN-401 which is packaged in an adeno-associated virus 9 that is in Phase 1/2 clinical trial for the treatment of Rett syndrome; and NGN-101, a conventional gene therapy candidate that is in Phase 1/2 clinical trial to treat CLN5 Batten disease. It has a license agreement with The University of North Carolina, the University of Edinburgh, Virovek, Inc., and Sigma-Aldrich Co. LLC. The company is headquartered in New York, New York.

Neurogene Inc Financial Data Overview

44.83
43.55
-
45.1299
42.46
12.2-53
407 M
12 824 K
0
-1
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'NGNE',
Type: 'Common Stock',
Name: 'Neurogene Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG005Y0QDK1',
ISIN: NULL,
CUSIP: NULL,
CIK: '1404644',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2014-03-07',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

Neurogene Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -50 428 000
  • Earnings Per Share
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Neurogene Inc Earnings via APIs

  • Latest Release 2024-05-10
  • EPS/Forecast -1.13

Get Neurogene Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Neurogene Inc latest news via APIs

7 A-Rated Aggressive Biotech Stocks to Bet On in 2024

The best biotech stocks to buy are in companies that put a lot of resources into research and development, often with nothing to show for it for years. Regulatory hurdles make finding biotech stocks ...
Do you have any questions?
support@eodhistoricaldata.com